Accelerate Diagnostics reported 492.01M in Market Capitalization for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Abbott ABT:US $ 205.99B 6.31B
Accelerate Diagnostics AXDX:US 492.01M 17.39M
Becton, Dickinson and BDX:US $ 69.84B 870.74M
Bio Rad Laboratories BIO:US $ 19.15B 2.06B
Bruker BRKR:US $ 11.51B 1.77B
Danaher DHR:US $ 191.42B 30.92B
Exact Sciences EXAS:US $ 21.33B 957.64M
Genmark Diagnostics GNMK:US $ 1.05B 37.91M
Hologic HOLX:US $ 17.1B 2.07B
Illumina ILMN:US $ 69.09B 13.02B
Luminex LMNX:US $ 1.51B 433.34M
Meridian Bioscience VIVO:US $ 961.06M 171.5M
Myriad Genetics MYGN:US $ 2.36B 33M
Nanostring Technologies NSTG:US $ 2.93B 339.47K
Oxford Immunotec Global OXFD:US 303.75M 33.67M
Pacific Biosciences Of California PACB:US $ 6.94B 504.85M
Perkinelmer PKI:US $ 17.31B 2.93B
Quidel QDEL:US $ 5.45B 9.11M
Thermo Fisher Scientific TMO:US $ 198.27B 18.91B